Intern, Clinical Operations

This role will assist with building an end-to-end process for either Clinical Study Conduct or Clinical Study Close-out. These projects aim to create road maps for our staff to understand the end-to-end process and not just their role, and to successfully navigate these key and cross-functionally complex stages of clinical trial conduct by bringing together the dozens of processes across Development. Responsibilities may include, but are not limited to:

• Assist in identifying key process steps and corresponding key roles involved in the end-to-end process for either Clinical Study Conduct and/or Clinical Study Close-out.
• Assist with the translation of these process steps into corresponding documents such as Standard Operating Procedures (SOPs), Work Instructions (WI), Workflows, and managed layer documents.
• Participate in process meetings, assisting with meeting minutes and documentation of key points.
• Support project timelines, milestones, and communication.

Learning Outcomes

1. Learning Objective #1: Better understanding of Good Clinical Practice expectations for sponsors

2. Learning Objective #2: A cross-functional awareness of how we conduct clinical trials at Alnylam, and an understanding of the roles involved and their responsibilities.

3. Learning Objective #3: Experience identifying process current state, facilitating cross-functional process mapping and using process design to lower risk and increase effectiveness

Qualifications

• Working towards a bachelor's degree in health sciences
• Basic knowledge of drug development process
• Project/process management experience
• Strong written and verbal communication skills
• Attention to detail
• Proficient with MS Office Suite (Excel, Word and PowerPoint)
• General knowledge of process flows preferred
• Previous industry experience preferred
• Legal authorization to work in the U.S.
• At least 18 years of age prior to scheduled start date

This is a full-time 10-12 weeks assignment spanning approximately May 20 - Aug 29

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.